CJC-1295/Ipamorelin = not FDA-approved, off-label adult use through compounding pharmacies
Although oral tablet form is preferred, injection is not advised during pregnancy or lactation due to the presence of benzyl alcohol
Dont wait another day to take control of your health.
In phase III: Semaglutide 2.4 mg (STEP-1): nausea 44.2%, diarrhea 31.5%, vomiting 24.8% Tirzepatide 15 mg (SURMOUNT-1): nausea 29.2%, diarrhea 23.0%, constipation 16.8% Retatrutide 12 mg (TRIUMPH-1): nausea 37.2%, vomiting 22.0%, diarrhea 27.1% Key observation: tirzepatide shows the most favorable GI profile at equivalent dose, likely tied to the GIP component dampening GLP-1-mediated nausea signaling at the brainstem level
this timing allows your body to properly absorb the semaglutide
10.4103/1673-5374.276324 69 ReisA